Search

Author/Creator Hazzan, Rawi

2. GARNET: High SVR Rates Following Eight‐Week Treatment with Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir for Patients with HCV Genotype 1b Infection: 888. (October 2016)

Authors:
Welzel, Tania M.; Zeuzem, Stefan; Dumas, Emily O.; Asselah, Tarik; Shaw, David; Hazzan, Rawi; Forns, Xavier; Pilot‐Matias, Tami; Lu, Wenjing; Cohen, Daniel E.; Feld, Jordan
Journal:
American journal of gastroenterology
Issue:
Volume 111(2016)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. HCV Genotype-1 Subtypes and Resistance-Associated Substitutions in Drug-Naive and in Direct-Acting Antiviral Treatment Failure Patients. Issue 5 (July 2017)

Authors:
Gozlan, Yael; Ben-Ari, Ziv; Moscona, Roy; Shirazi, Rachel; Rakovsky, Aviya; Kabat, Arij; Veizman, Ella; Berdichevski, Tania; Weiss, Peretz; Cohen-Ezra, Oranit; Lurie, Yoav; Gafanovich, Inna; Braun, Marius; Cohen-Naftaly, Michal; Shlomai, Amir; Shibolet, Oren; Zigmond, Ehud; Zuckerman, Eli; Carmie...
Journal:
Antiviral therapy
Issue:
Volume 22:Issue 5(2017)
Page Start:
431
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. High Frequency of Multiclass HCV Resistance-Associated Mutations in Patients Failing Direct-Acting Antivirals: Real-Life Data. Issue 3 (April 2019)

Authors:
Gozlan, Yael; Bucris, Efrat; Shirazi, Rachel; Rakovsky, Avia; Ben-Ari, Ziv; Davidov, Yana; Veizman, Ella; Saadi, Tarek; Braun, Marius; Cohen-Naftaly, Michal; Shlomai, Amir; Shibolet, Oren; Zigmond, Ehud; Katchman, Helena; Menachem, Yoram; Safadi, Rifaat; Galun, Eitan; Zuckerman, Eli; Nimer, Assy;...
Journal:
Antiviral therapy
Issue:
Volume 24:Issue 3(2019)
Page Start:
221
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial. (July 2017)

Authors:
Welzel, Tania M; Asselah, Tarik; Dumas, Emily O; Zeuzem, Stefan; Shaw, David; Hazzan, Rawi; Forns, Xavier; Pilot-Matias, Tami; Lu, Wenjing; Cohen, Daniel E; Feld, Jordan J
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 2:Number 7(2017)
Page Start:
494
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗